Primary Immune Response Provides Protective Efficacy against SARS-CoV-2 Reinfection

While there is absolutely no evidence to ensure recovered patients are either likely or unlikely to get reinfected. But studies in non-human primates indicate that reinfection of recovered patients is highly unlikely. It is also clear that primary immune responses or induced immunity to severe acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrestha, Rupendra, Shrestha, Reena, Khadka, Ram Bahadur, Gyawali, Rabin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of the Nepal Medical Association 2021
Materias:
View Point
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107855/
https://www.ncbi.nlm.nih.gov/pubmed/34508515
http://dx.doi.org/10.31729/jnma.5538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107855/
https://www.ncbi.nlm.nih.gov/pubmed/34508515
http://dx.doi.org/10.31729/jnma.5538

Ejemplares similares